IN.PACT AV access randomized trial: Japan cohort outcomes through 12 months

Purpose There is a lack of adjudicated and prospectively randomized published outcomes on the use of drug‐coated balloons (DCB) to treat dysfunctional arteriovenous fistula in Asian patients. This post hoc subgroup analysis of 112 Japanese participants from the global IN.PACT AV Access trial reports outcomes through 12 months. Materials and Methods Participants were treated with DCB (n = 58) or standard non‐coated percutaneous transluminal angioplasty (PTA) balloons (n = 54). Outcomes included target lesion primary patency (TLPP), access circuit primary patency, and safety. Results Through 6 months, TLPP was 86.0% (49/57) in the DCB group and 49.1% (26/53) in the PTA group (p